sGCα1-deficient mice: a novel murine model of spontaneous primary open angle glaucoma

Background Primary open angle glaucoma (POAG) is a progressive eye disease that leads to blindness due to the irreversible loss of retinal ganglion cells and degeneration of the optic nerve (ON). As of yet, there is no cure for glaucoma. Although available therapies delay disease progression, they offer incomplete protection. Elevated intraocular pressure (IOP) is an important risk factor for POAG. However, the exact molecular mechanisms that trigger increased IOP and glaucomatous optic neuropathy remain incompletely understood. While a few spontaneous murine models of glaucoma exist, none are models of POAG, the most prevalent form of glaucoma. Impaired nitric oxide (NO) signaling has been implicated in the development of glaucoma. To further test the hypothesis that impaired NO/cGMP signaling contributes to the pathogenesis of POAG, we tested whether mice lacking the a1 subunit of the NO receptor soluble guanylate cyclase (sGCa1 -/mice) develop POAG.